{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:47:17Z","timestamp":1776692837273,"version":"3.51.2"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The aim of this study was to compare the clinical features, predictors, and clinical outcomes of patients hospitalized with acute heart failure (AHF), with and without worsening heart failure (WHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We used data from a multicentre prospective registry of AHF patients created in Saudi Arabia. WHF was defined as recurrence of heart failure symptoms or signs\u2014with or without cardiogenic shock. In-hospital short- and long-term outcomes, as well as predictors of WHF are described. Of the 2609 AHF patients enrolled, 33.8% developed WHF. WHF patients were more likely to have a history of heart failure and ischaemic heart disease. Use of intravenous vasodilators, inotropic agents, furosemide infusions, and discharge beta-blockers was significantly higher in WHF patients, while use of discharge ACE inhibitors was higher in patients without WHF. Length of hospital stay was significantly longer for WHF patients than for those without WHF [median (interquartile range) 13 (14) vs. 7 (7) days, P &amp;lt; 0.001]. In-hospital, 30-day, 1-year, and 2-year mortality rates were higher in WHF patients than in non-WHF patients. The adjusted odds ratios for in-hospital, 30-day, and 1-year mortality were 4.13 [95% confidence interval (CI) 2.74\u20136.20, P &amp;lt; 0.001], 3.17 (95% CI 2.21\u20134.56, P &amp;lt; 0.001), and 1.34 (95% CI 1.04\u20131.71, P = 0.021), respectively. The strongest predictors for WHF were having ischaemic cardiomyopathy, AHF with concomitant acute coronary syndrome, and low haemoglobin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In real-world clinical practice, WHF during hospitalization for AHF is a strong predictor for short- and intermediate-term mortality, and a cause for longer hospital stays.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.515","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T23:17:28Z","timestamp":1460503048000},"page":"987-995","source":"Crossref","is-referenced-by-count":18,"title":["Worsening Heart Failure in \u2018Real-World\u2019 Clinical Practice: Predictors and Prognostic Impact"],"prefix":"10.1093","volume":"19","author":[{"given":"Hussam","family":"AlFaleh","sequence":"first","affiliation":[{"name":"Department of Cardiac Sciences, College of Medicine, King Saud University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelfatah A.","family":"Elasfar","sequence":"additional","affiliation":[{"name":"King Salman Heart Center, King Fahd Medical City , Riyadh ,","place":["Saudi Arabia"]},{"name":"Cardiology Department Tanta University \u00a0","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anhar","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, College of Medicine, King Saud University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid F.","family":"AlHabib","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, College of Medicine, King Saud University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Hersi","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, College of Medicine, King Saud University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layth","family":"Mimish","sequence":"additional","affiliation":[{"name":"King Abdulaziz University Hospital, King Abdulaziz University , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Almasood","sequence":"additional","affiliation":[{"name":"Prince Sultan Cardiac Center , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Al Ghamdi","sequence":"additional","affiliation":[{"name":"Madina Cardiac Center, Al Madina Al Monaoarah \u00a0","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Ghabashi","sequence":"additional","affiliation":[{"name":"King Abdullah Medical City, Cardiac center , Makkah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Malik","sequence":"additional","affiliation":[{"name":"King Fahad General Hospital , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal A.","family":"Hussein","sequence":"additional","affiliation":[{"name":"North West Armed Forces Hospital , Tabuk ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushabab","family":"Al-Murayeh","sequence":"additional","affiliation":[{"name":"Armed Forces Hospital Southern Region , Khamis Mushayt ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abuosa","sequence":"additional","affiliation":[{"name":"National Guard Hospital , Jeddah ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Al Habeeb","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, College of Medicine, King Saud University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Kashour","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, College of Medicine, King Saud University , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"2026011721192114000_ejhf515-bib-0001","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur Heart J"},{"key":"2026011721192114000_ejhf515-bib-0002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ejhf.57","article-title":"Clinical features, management, and short- and long-term outcomes of patients with acute decompensated heart failure: phase I results of the HEARTS database","volume":"16","author":"AlHabib","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0003","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ejhf.245","article-title":"Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE)","volume":"17","author":"Sulaiman","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0004","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011721192114000_ejhf515-bib-0005","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"2026011721192114000_ejhf515-bib-0006","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J Cardiac Fail"},{"key":"2026011721192114000_ejhf515-bib-0007","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"2026011721192114000_ejhf515-bib-0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"2026011721192114000_ejhf515-bib-0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet"},{"key":"2026011721192114000_ejhf515-bib-0011","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"},{"key":"2026011721192114000_ejhf515-bib-0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001088","article-title":"In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization","volume":"3","author":"DeVore","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026011721192114000_ejhf515-bib-0013","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jchf.2015.01.007","article-title":"Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies","volume":"3","author":"Davison","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0014","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ahj.2015.04.007","article-title":"Worsening heart failure during hospitalization for acute heart failure: insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)","volume":"170","author":"Kelly","year":"2015","journal-title":"Am Heart J"},{"key":"2026011721192114000_ejhf515-bib-0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ejhf.308","article-title":"Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial","volume":"17","author":"Mentz","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0016","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cardfail.2009.04.001","article-title":"Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome","volume":"15","author":"Torre-Amione","year":"2009","journal-title":"J Cardiac Fail"},{"key":"2026011721192114000_ejhf515-bib-0017","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/eurjhf\/hfr111","article-title":"Design and preliminary results of the heart function assessment registry trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure","volume":"13","author":"AlHabib","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0018","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0019","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(01)01702-8","article-title":"American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)","volume":"38","author":"Cannon","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026011721192114000_ejhf515-bib-0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026011721192114000_ejhf515-bib-0021","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ejhf.333","article-title":"In-hospital worsening heart failure","volume":"17","author":"Butler","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0022","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"2026011721192114000_ejhf515-bib-0023","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0735-1097(03)00194-3","article-title":"Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)","volume":"41","author":"O'Connor","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011721192114000_ejhf515-bib-0024","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials","volume":"298","author":"McMurray","year":"2007","journal-title":"JAMA"},{"key":"2026011721192114000_ejhf515-bib-0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011721192114000_ejhf515-bib-0026","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/ejhf.186","article-title":"Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study","volume":"16","author":"Cotter","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0027","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/eurjhf\/hfq021","article-title":"Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study","volume":"12","author":"Metra","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721192114000_ejhf515-bib-0028","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1472-8206.2009.00697.x","article-title":"Early worsening heart failure in patients admitted with acute heart failure\u2014a new outcome measure associated with long-term prognosis?","volume":"23","author":"Weatherley","year":"2009","journal-title":"Fund Clin Pharmacol"},{"key":"2026011721192114000_ejhf515-bib-0029","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"2026011721192114000_ejhf515-bib-0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjcard.2012.10.042","article-title":"Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)","volume":"111","author":"Greene","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026011721192114000_ejhf515-bib-0031","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijcard.2012.09.128","article-title":"Long-term survival after hospitalization for acute heart failure\u2014differences in prognosis of acutely decompensated chronic and new-onset acute heart failure","volume":"168","author":"Lassus","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026011721192114000_ejhf515-bib-0032","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.515","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/19\/8\/987\/66328499\/eurjhf_19_8_987.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/19\/8\/987\/66328499\/eurjhf_19_8_987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:21:19Z","timestamp":1768702879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/19\/8\/987\/8418557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,4,12]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.515","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2016,4,12]]}}}